37 related articles for article (PubMed ID: 21906125)
21. Expression and prognostic significance of metalloproteases and their inhibitors in luminal A and basal-like phenotypes of breast carcinoma.
González LO; Corte MD; Junquera S; González-Fernández R; del Casar JM; García C; Andicoechea A; Vázquez J; Pérez-Fernández R; Vizoso FJ
Hum Pathol; 2009 Sep; 40(9):1224-33. PubMed ID: 19439346
[TBL] [Abstract][Full Text] [Related]
22. FOXA1 expression in breast cancer--correlation with luminal subtype A and survival.
Badve S; Turbin D; Thorat MA; Morimiya A; Nielsen TO; Perou CM; Dunn S; Huntsman DG; Nakshatri H
Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4415-21. PubMed ID: 17671124
[TBL] [Abstract][Full Text] [Related]
23. [Molecular taxonomy of luminal breast cancer in 2015].
Franchet C; Duprez-Paumier R; Lacroix-Triki M
Bull Cancer; 2015 Jun; 102(6 Suppl 1):S34-46. PubMed ID: 26118875
[TBL] [Abstract][Full Text] [Related]
24. "New" molecular taxonomy in breast cancer.
Hergueta-Redondo M; Palacios J; Cano A; Moreno-Bueno G
Clin Transl Oncol; 2008 Dec; 10(12):777-85. PubMed ID: 19068448
[TBL] [Abstract][Full Text] [Related]
25. [Breast cancer: new concepts in classification].
Vieira DS; Dufloth RM; Schmitt FC; Zeferino LC
Rev Bras Ginecol Obstet; 2008 Jan; 30(1):42-7. PubMed ID: 19142542
[TBL] [Abstract][Full Text] [Related]
26. Expression profiling technology: its contribution to our understanding of breast cancer.
Rakha EA; El-Sayed ME; Reis-Filho JS; Ellis IO
Histopathology; 2008 Jan; 52(1):67-81. PubMed ID: 18171418
[TBL] [Abstract][Full Text] [Related]
27. A review of the biological and clinical characteristics of luminal-like oestrogen receptor-positive breast cancer.
Habashy HO; Powe DG; Abdel-Fatah TM; Gee JM; Nicholson RI; Green AR; Rakha EA; Ellis IO
Histopathology; 2012 May; 60(6):854-63. PubMed ID: 21906125
[TBL] [Abstract][Full Text] [Related]
28. Molecular analysis of hormone receptor positive (luminal) breast cancers: what have we learnt?
Loi S
Eur J Cancer; 2008 Dec; 44(18):2813-8. PubMed ID: 18990560
[TBL] [Abstract][Full Text] [Related]
29. Oestrogen-receptor-positive breast cancer: towards bridging histopathological and molecular classifications.
Badve S; Nakshatri H
J Clin Pathol; 2009 Jan; 62(1):6-12. PubMed ID: 18794199
[TBL] [Abstract][Full Text] [Related]
30. Linkage between EGFR family receptors and nuclear factor kappaB (NF-kappaB) signaling in breast cancer.
Biswas DK; Iglehart JD
J Cell Physiol; 2006 Dec; 209(3):645-52. PubMed ID: 17001676
[TBL] [Abstract][Full Text] [Related]
31. Gene expression profiles of the oestrogen receptor in breast cancer.
Kok M; Linn SC
Neth J Med; 2010 Oct; 68(10):291-302. PubMed ID: 21071774
[TBL] [Abstract][Full Text] [Related]
32. Molecular classification of estrogen receptor-positive/luminal breast cancers.
Geyer FC; Rodrigues DN; Weigelt B; Reis-Filho JS
Adv Anat Pathol; 2012 Jan; 19(1):39-53. PubMed ID: 22156833
[TBL] [Abstract][Full Text] [Related]
33.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
34.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]
